Sanjeev Pathak

Senior Vice President, Head Of Clinical Development at Acadia Pharmaceuticals

Sanjeev Pathak, M.D., is the Senior Vice President, Head of Clinical Development.

Dr. Pathak is a pediatric and adult psychiatrist as well as a clinical neuroscientist with more than 20 years of experience in drug development and clinical research. His experience spans both common and rare diseases including neurodevelopmental, neurodegenerative and neuropsychiatric disorders. He has led or supported teams in achieving approvals for Seroquel® (quetiapine), Seroquel XR® (quetiapine), Aristada® (aripiprazole lauroxil) and LYBALVI® (olanzapine/samidorphan).

Prior to joining Acadia, Dr. Pathak served as Vice President of Clinical Development at Alkermes. Prior to Alkermes, he held roles of increasing responsibility at AstraZeneca and led clinical development efforts across all phases of development. Before transitioning to the industry, he was Assistant Professor of Psychiatry and Pediatrics at University of Cincinnati, College of Medicine.

Over the years, Dr. Pathak has been a practicing physician and brings these lessons to clinical development. He completed his residency and fellowship trainings at University of Cincinnati, College of Medicine Cincinnati Children’s Hospital Medical Center and received his medical training from the top medical school in India, the All-India Institute of Medical Science.

Location

Waltham, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Acadia Pharmaceuticals

3 followers

Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.


Industries

Employees

501-1,000

Links